Researchers explored the role of gut microbiota in patients with psoriatic arthritis (PsA), particularly those presenting with enthesitis and dactylitis, compared to patients with undifferentiated arthritis lacking these...
Robert Laugherty,
JD, MBA, PA-C
Physician Assistant and Director of Rheumatology, East Tennessee Medical Group
The Cost of Delayed Psoriatic Arthritis Diagnosis and Treatment
A recent, large, real-world study compared early diagnostic and treatment outcomes for patients with psoriatic arthritis (PsA) and rheumatoid arthritis...
Multimorbidity May Signal Early Psoriatic Arthritis Risk
A population-based cohort study using the Rochester Epidemiology Project assessed the relationship between multimorbidity and the development of psoriatic arthritis...
SOX5 Autoantibodies Emerge as Potential Biomarker for Psoriatic Disease Subgroups
This study identified a novel class of autoantibodies in psoriatic arthritis (PsA) that target SOX-D transcription factors—specifically SOX5, SOX6, and...
